Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CD27 Recombinant monoclonal antibody (LG.3A10)

ENZ-ABS799-0200 200 µg 466.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:TNFRSF7, CD27L receptor, T-cell activation antigen CD27
Immunogen:This antibody was produced by injecting Armenian hamsters intraperitoneally with a mixture of two murine CD27 tag-expressing Armenian hamster fibroblast clones (AR0524 and AR0530) in Freund's adjuvant.
UniProt ID:P41272
Source:This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.
Species reactivity:Mouse
Applications:ELISA, IF
Purity Detail:Protein A affinity purified.
Formulation:Liquid. In PBS containing 0.02% Proclin 300.
Use/Stability:Stable at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
Handling:Avoid freeze/thaw cycles.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
CD27 Recombinant monoclonal antibody (LG.3A10) ELISA
Binding curve of CD27 antibody to mouse CD27-Fc fusion protein.
CD27 Recombinant monoclonal antibody (LG.3A10) IF
Immunofluorescence staining of fixed mouse splenocytes with ENZ-ABS799. Immunofluorescence analysis of paraformaldehyde fixed mouse (Mus musculus) splenocytes. Panels show from left-right, top-bottom ENZ-ABS799, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody (Ab102-23.0) followed by Alexa Fluor® 488 secondary antibody.
Please mouse over
CD27 Recombinant monoclonal antibody (LG.3A10) ELISA CD27 Recombinant monoclonal antibody (LG.3A10) IF

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
CD27 Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,